ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
Triple-negative breast cancer (TNBC) remains one of the most aggressive and therapeutically challenging breast cancer subtypes. In their recent study, Cao et al introduced a B7H3-specific chimeric antigen receptor (CAR)-T cell with constitutive inducible co-stimulator (ICOS) expression (ICOS-B7H3-CA...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMJ Publishing Group
2025-03-01
|
| Серія: | Journal for ImmunoTherapy of Cancer |
| Онлайн доступ: | https://jitc.bmj.com/content/13/3/e011564.full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|